107 filings
Page 2 of 6
8-K
21ur9v3jgmb
8 May 23
Prelude Therapeutics Announces First Quarter 2023 Financial Results and Operations Update
8:06am
ARS
2phgydndg8 g1pvbhf
28 Apr 23
Annual report to shareholders
9:46am
DEFA14A
npzh5h 9xsgpt
28 Apr 23
Additional proxy soliciting materials
9:41am
PRE 14A
sqe70 ragrh
18 Apr 23
Preliminary proxy
4:00pm
8-K
7pfi0i7xfyqi 682dz0
15 Mar 23
Entry into a Material Definitive Agreement
4:38pm
424B5
8r1i4v1dy0n
15 Mar 23
Prospectus supplement for primary offering
4:33pm
S-8
243f5jhffpkj 3r2
15 Mar 23
Registration of securities for employees
9:17am
8-K
5277rbz2
15 Mar 23
Prelude Therapeutics Reports Full Year 2022 Financial Results and Provides Corporate Update
8:31am
8-K
l4f9j7hl1bynvdqz6
14 Feb 23
Regulation FD Disclosure
11:14am
8-K
cmp7reubfc3r81 oev7m
23 Jan 23
Amendments to Articles of Incorporation or Bylaws
4:16pm
8-K
x3j7a bk5b
9 Jan 23
Regulation FD Disclosure
8:01am
8-K
y5uhh0
14 Nov 22
Prelude Therapeutics Announces Third Quarter 2022 Financial Results and Provides Business Update
8:21am
8-K
1fpdfpjp4i sdws8oy
9 Aug 22
Prelude Therapeutics Announces Second Quarter 2022 Financial Results and Business Update
8:02am
8-K
bbv0myqb6u 8nmh
21 Jun 22
Submission of Matters to a Vote of Security Holders
8:00am